Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer: A Multicenter, Retrospective Study
Yosuke Kakiuchi, K. Saruwatari, K. Murotani, T. Tokito, Toyohisa Iriki, Jun Iwakawa, Y. Sakata, Naoki Shingu, S. Saeki, M. Inaba, Akira Takaki, Shunsuke Misono, T. Suetsugu, Koichi Azuma, Keiko Mizuno, T. Sakagami
{"title":"Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer: A Multicenter, Retrospective Study","authors":"Yosuke Kakiuchi, K. Saruwatari, K. Murotani, T. Tokito, Toyohisa Iriki, Jun Iwakawa, Y. Sakata, Naoki Shingu, S. Saeki, M. Inaba, Akira Takaki, Shunsuke Misono, T. Suetsugu, Koichi Azuma, Keiko Mizuno, T. Sakagami","doi":"10.1016/j.cllc.2024.07.001","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10490,"journal":{"name":"Clinical lung cancer","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical lung cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cllc.2024.07.001","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.